Table 9.8b

Adjusted Graft Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	874	86.5%	1.2%	874	80.3%	1.4%	641	68.6%	1.9%	177	63.4%	4.8%
Primary Diagnosis	Non-Cholestatic Cirrhosis	475	88.6%	1.6%	475	81.5%	2.0%	270	68.1%	3.0%	29	49.5%	9.3%
	Cholestatic Liver Disease/Cirrhosis	150	85.5%	3.0%	150	82.0%	3.3%	93	71.7%	4.7%	9	79.9%	12.3%
	Acute Hepatic Necrosis	43	80.1%	6.2%	43	71.2%	7.2%	48	52.9%	8.4%	13	92.6%	6.8%
	Biliary Atresia	79	84.4%	4.9%	79	80.8%	5.6%	100	73.8%	6.7%	87	77.7%	4.5%
	Metabolic Diseases	25	87.9%	6.4%	25	71.9%	8.9%	29	70.7%	9.5%	15	73.0%	11.1%
	Malignant Neoplasms	44	79.8%	5.9%	44	70.8%	6.7%	52	64.3%	6.5%	2	41.7%	26.3%
	Other	58	83.5%	5.1%	58	81.8%	5.4%	49	76.6%	6.8%	22	55.5%	10.8%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Graft survival follows individual transplants until graft failure.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.